By capturing the transcriptomic profiles of individual cells, scRNA‐seq enables precise characterization of malignant and immune cell states, facilitates the identification of prognostic markers such as AIMP1 and CNIH4 in HNSCC, and reveals novel functional roles of key regulators such as the VGSC β3 subunit in glioma.179, 180, 181. This evidence concerns the gene AIMP1 and glioma.